Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
200
Trial Sponsor
Clinical Trial Start Date
September 4, 2014
0Primary Completion Date
December 19, 2016
0Study Completion Date
December 19, 2016
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Behavioral0
Drug0
Intervention Name
Placebo0
Manual-guided behavioral counseling0
aprepitant0
Interventional Trial Phase
Phase 20
Participating Facility
Official Name
Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence0
Last Updated
August 2, 2017
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Quadruple0
Masked Party
Care Provider0
Participant0
Outcomes Assessor0
Investigator0
Study summary
The primary aim of the supplemental study is to provide POC testing of aprepitant as a treatment for comorbid alcohol and cannabis dependence. The data analysis plan specified in the parent grant will likewise be applied to the supplemental project to test for effects of aprepitant vs placebo on measures of alcohol and cannabis use and protracted withdrawal. The primary hypothesis is that subjects treated with aprepitant will have significantly less alcohol and marijuana use than subjects treated with placebo.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
